BIB

Fund Description
ProShares Ultra Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.
Fund Profile
Fund Name ProShares Ultra Nasdaq Biotechnology
Fund Exchange Ticker BIB
Fund Sponsor ProShares
Fund ISIN US74347R2141
Net Expense Ratio 0.95 %
Fund Inception Date 7 April 2010
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Nasdaq Biotech Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Leveraged (2x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 23 November 2022
Asset Under Management 112.65 Million (USD)
1 Month Total Return 9.54 %
Year To Date Return -26.97 %
1 Year Total Return -26.12 %
3 Year Annualized Total Return -0.24 %
NAV 59.2883
Share Outstanding 1,900,000
Top 10 Holdings (25 November 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
NASDAQ Bio Index SWAP BNP SWAP 0.2394620341
NASDAQ Biotechnology Index SWAP Goldman Sachs International SWAP 0.2379950188
NASDAQ Biotechnology Index SWAP Societe Generale SWAP 0.2179458099
Net Other Assets (Liabilities) OTHR 0.1922312295
NASDAQ Biotechnology Index SWAP UBS AG SWAP 0.1899220563
NASDAQ Biotechnology Index SWAP Citibank NA SWAP 0.1407582362
NASDAQ Biotechnology Index SWAP Bank of America NA SWAP 0.1259376202
GILEAD SCIENCES INC GILD EQUI 0.0803290546
AMGEN INC AMGN EQUI 0.0697916508
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0598020654